In Reply to Xue W, Ribalov R, Zhou Z-Y, et al. Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103-113.

Subjects

Subjects :

Cost-Benefit Analysis
Humans
Tetrabenazine analogs & derivatives
Tetrabenazine therapeutic use
Valine analogs & derivatives
Antipsychotic Agents
Tardive Dyskinesia drug therapy

Details

Language :

English

ISSN :

1941-837X

Volume :

24

Issue :

1

Database :

MEDLINE

Journal :

Journal of medical economics

Publication Type :

Academic Journal

Accession number :

34166165

Full Text :

https://doi.org/10.1080/13696998.2021.1948233